Botanical species · safety record

Geranium sanguineum

The EFSA Compendium of Botanicals holds 5 constituent measurements for Geranium sanguineum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Geranium sanguineum L.

5Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Gallotannins1
  • Lectins1
  • Proanthocyanidins (condensed tannins)1
  • Tannins1
  • Vernolic acid1

Plant parts

  • Roots and other underground parts2
  • Leaves1
  • Live plants1
  • Seed1

Preparations

  • Solvent extraction5

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
GallotanninsLeavesSolvent extractionUnspecifiedResolve DOI
Vernolic acidSeedSolvent extractionGC-MSResolve DOI
LectinsLive plantsSolvent extractionHemagglutination inhibition testNo resolvable identifier
Proanthocyanidins (condensed tannins)Roots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
TanninsRoots and other underground partsSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Tsevegsuren, N., Aitzetmuller, K., Vosmann, K. Geranium sanguineum (Geraniaceae) seed oil: A new source of petroselinic and vernolic acid . Lipids, 2004, vol. 39, no. 6, p. 571-576. DOI
  2. Mavlyanov, S.M., Islambekov, Sh.Yu., Kamaev, F.G., Abdullaev, U.A., Karimdzhanov, A.K., Ismailov, A.I. Tannins of Geranium sanguineum. Chemistry of Natural Compounds, 1997, vol. 33, no. 2, p. 179-184.
  3. Rybak, Lyubov., Rudik, Galina. Research on quantitative content of lectins in plants of the Geranium L. genus. Pharma innovation, 2013, p. 38-41.
  4. Sekowski, Szymon., Ionov, Maksim., Kaszuba, Mateusz., Mavlyanov, Saidmukhtar., Bryszewska, Maria., Zamaraeva, Maria. Biophysical studies of interaction between hydrolysable tannins isolated from Oenothera gigas and Geranium sanguineum with human serum albumin . Colloids and surfaces b-biointerfaces, 2014, vol. 123, p. 623-628. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue